V
Power Law company profile
Valneva
Biotech & Life Sciences · Saint-Herblain, France · Founded 1999 · IPO 2013 Unicorn
Valuation
$588M
Market cap · Apr/2026
Revenue
$192M
Latest reported FY
Global footprint
Where Valneva has talent and traffic
AI talent share
0.2%
of workforce is AI talent
(1 of 642 staff)
(1 of 642 staff)
Core AI00%
Other AI10.16%
Non-AI workforce64199.84%
Web traffic by country
36K
monthly visits
across markets
across markets
🇫🇷 France25.3%
🇺🇸 United States9.4%
🇦🇹 Austria7.8%
🇬🇧 United Kingdom6.7%
🇮🇳 India4.7%
Patent intelligence
$70M patent portfolio · 27 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$70M
11.9% of market cap · 101.3× smaller than top peer Janssen Vaccines ($7.1B)
27 active patent families
Where Valneva innovates
AntigenMolecular biologyTGE VACCINENucleic acidAdjuvant
Tracks the peer median across all five Patsnap quality dimensions.
Quality vs same-sector peers
Valneva on the five Patsnap quality dimensions
Valneva in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Valneva concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Valneva and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Valneva on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.